Cellular thermal shift assay (CETSA) was employed to monitor the cellular target engagement of CC1007 and verify whether CC1007 could directly interact with MEF2C in BCR-ABL1− pre-B-ALL cells. Here, BCR is linked to acute lymphoblastic leukemia.